Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Hemoglobin ; 44(6): 432-437, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33059511

RESUMO

Thalassemia and hemoglobinopathies are the most common cause of high morbidity and mortality in India. Detection of carriers and premarital counseling play an important role in preventing the birth of a thalassemic child. The present study aimed to detect large numbers of asymptomatic carriers in rural areas of West Bengal, India. The present cross-sectional study was conducted over a period of 10 years. Thalassemia awareness programs and detection camps were organized at the community level. After signed written consent was obtained, the collected blood samples were subjected to a complete blood count (CBC) in an automated blood cell counter and then analyzed by high performance liquid chromatography (HPLC); in difficult cases, samples were sent to the reference laboratory for molecular characterization. Out of 287,258 samples collected, 32,921 (11.46%) cases revealed abnormal hemoglobins (Hbs); of these, 31,782 (11.06%) carried heterozygous states (carriers/traits), and the remainder were either homozygous or compound heterozygous for different hemoglobinopathies. Two common variants were revealed in the study, namely ß-thalassemia (ß-thal) (7.23%) and Hb E [ß26(B8)Glu→Lys, HBB: c.79G>A] (2.77%) traits. Among homozygous or compound heterozygous states, Hb E/ß-thal (0.14%) and ß-thal major (ß-TM) (0.12%) were predominant. In rural areas of West Bengal, the most common Hb variants detected were ß-thal and Hb E traits. In view of the high prevalence of hemoglobinopathies in this region, routine premarital screening and genetic counseling should be emphasized and encouraged to prevent the birth of a thalassemic child, and thus curtailing the burden on families and the health economy.


Assuntos
Hemoglobinopatias/epidemiologia , População Rural , Talassemia alfa/epidemiologia , Talassemia beta/epidemiologia , Alelos , Biomarcadores , Cromatografia Líquida de Alta Pressão , Estudos Transversais , Índices de Eritrócitos , Genótipo , Hemoglobinopatias/diagnóstico , Hemoglobinopatias/etiologia , Humanos , Índia/epidemiologia , Programas de Rastreamento , Vigilância da População , Prevalência , alfa-Globinas/genética , Talassemia alfa/diagnóstico , Talassemia alfa/etiologia , Globinas beta/genética , Talassemia beta/diagnóstico , Talassemia beta/etiologia
2.
Appl Biochem Biotechnol ; 175(7): 3371-86, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25649444

RESUMO

This study aimed to explore the bactericidal activity of a feather-degraded active peptide against multiple-antibiotic-resistant (MAR) Staphylococcus aureus. An antibacterial peptide (ABP) was isolated from the chicken feathers containing fermented media of Paenibacillus woosongensis TKB2, a keratinolytic soil isolate. It was purified by HPLC, and its mass was found to be 4666.87 Da using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) spectroscopy. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of this peptide were 22.5 and 90 µg/ml, respectively. SEM study revealed the distorted cell wall of the test strain along with pore formation. The possible reason for bactericidal activity of the peptide is due to generation of reactive oxygen species (ROS), resulting in membrane damage and leakage of intracellular protein. Complete sequence of the peptide was predicted and retrieved from the sequence database of chicken feather keratin after in silico trypsin digestion using ExPASy tools. Further, net charge, hydrophobicity (77.7 %) and molecular modelling of the peptide were evaluated for better understanding of its mode of action. The hydrophobic region (17 to 27) of the peptide may facilitate for initial attachment on the bacterial membrane. The ABP exhibited no adverse effects on RBC membrane and HT-29 human cell line. This cytosafe peptide can be exploited as an effective therapeutic agent to combat Staphylococcal infections.


Assuntos
Farmacorresistência Bacteriana/imunologia , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Peptídeos/administração & dosagem , Infecções Estafilocócicas/imunologia , Animais , Galinhas/imunologia , Cromatografia Líquida de Alta Pressão , Plumas/química , Plumas/imunologia , Humanos , Staphylococcus aureus Resistente à Meticilina/imunologia , Testes de Sensibilidade Microbiana , Peptídeos/imunologia , Peptídeos/isolamento & purificação , Infecções Estafilocócicas/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA